Search details
1.
Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation.
Value Health
; 2024 Mar 14.
Article
in English
| MEDLINE | ID: mdl-38492923
2.
Prevalence of hepatitis B and C infection and linkage to care among patients with Non-Communicable Diseases in three rural Rwandan districts: a retrospective cross-sectional study.
BMC Infect Dis
; 24(1): 247, 2024 Feb 23.
Article
in English
| MEDLINE | ID: mdl-38388353
3.
Strategies for Removal of Barriers to Hepatitis C Elimination in Sub-Saharan Africa.
J Infect Dis
; 228(Suppl 3): S221-S225, 2023 09 13.
Article
in English
| MEDLINE | ID: mdl-37703337
4.
Lessons learned from global hepatitis C elimination programs.
J Infect Dis
; 2023 Sep 22.
Article
in English
| MEDLINE | ID: mdl-37739781
5.
Epidemiology of sexually transmitted infections: trends among patients screened for sexually transmitted infections in rwandan health facilities 2014-2020.
BMC Infect Dis
; 22(1): 701, 2022 Aug 20.
Article
in English
| MEDLINE | ID: mdl-35987614
6.
Time to complete hepatitis C cascade of care among patients identified during mass screening campaigns in rural Rwanda: a retrospective cohort study.
BMC Infect Dis
; 22(1): 272, 2022 Mar 21.
Article
in English
| MEDLINE | ID: mdl-35313817
7.
Effectiveness of Direct-acting Antivirals for the Treatment of Chronic Hepatitis C in Rwanda: A Retrospective Study.
Clin Infect Dis
; 73(9): e3300-e3307, 2021 11 02.
Article
in English
| MEDLINE | ID: mdl-32505127
8.
Risk factors for difficult-to-treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub-Saharan Africa.
J Viral Hepat
; 28(4): 682-686, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33421247
9.
Improved quality of life following direct-acting antiviral treatment for chronic hepatitis C infection in Rwanda: Results from a clinical trial in sub-Saharan Africa (the SHARED study).
J Viral Hepat
; 28(1): 112-120, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32858774
10.
Values and preferences for hepatitis C self-testing among the general population and healthcare workers in Rwanda.
BMC Infect Dis
; 21(1): 1064, 2021 Oct 14.
Article
in English
| MEDLINE | ID: mdl-34649503
11.
Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach.
BMC Infect Dis
; 21(1): 220, 2021 Feb 25.
Article
in English
| MEDLINE | ID: mdl-33632165
12.
Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.
BMC Public Health
; 20(1): 946, 2020 Jun 16.
Article
in English
| MEDLINE | ID: mdl-32546216
13.
Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda.
BMC Infect Dis
; 19(1): 381, 2019 May 03.
Article
in English
| MEDLINE | ID: mdl-31053097
14.
Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program.
BMC Infect Dis
; 19(1): 688, 2019 Aug 05.
Article
in English
| MEDLINE | ID: mdl-31382901
15.
Rwanda launches a 5-year national hepatitis C elimination plan: A landmark in sub-Saharan Africa.
J Hepatol
; 70(6): 1043-1045, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30948269
16.
The Cascade of Care for Hepatitis C Treatment in Rwanda: A Retrospective Cohort Study of the 2017-2019 Mass Screening and Treatment Campaign.
Viruses
; 15(3)2023 02 28.
Article
in English
| MEDLINE | ID: mdl-36992370
17.
Safety and efficacy of sofosbuvir-velpatasvir-voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial.
Lancet Gastroenterol Hepatol
; 7(6): 542-551, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35248212
18.
Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial.
Lancet Gastroenterol Hepatol
; 7(6): 533-541, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35248213
19.
Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study.
PLoS One
; 16(10): e0257917, 2021.
Article
in English
| MEDLINE | ID: mdl-34634039
20.
Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study.
BMJ Open
; 10(7): e036711, 2020 07 12.
Article
in English
| MEDLINE | ID: mdl-32660951